Genix Pharmaceuticals Corp
XTSX:GENX

Watchlist Manager
Genix Pharmaceuticals Corp Logo
Genix Pharmaceuticals Corp
XTSX:GENX
Watchlist
Price: 0.02 CAD
Market Cap: CA$1.2m

Genix Pharmaceuticals Corp
Long-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Genix Pharmaceuticals Corp
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Genix Pharmaceuticals Corp
XTSX:GENX
Long-Term Debt
CA$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Flora Growth Corp
NASDAQ:FLGC
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vitality Products Inc
XTSX:VPI
Long-Term Debt
CA$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jamieson Wellness Inc
TSX:JWEL
Long-Term Debt
CA$441.2m
CAGR 3-Years
-2%
CAGR 5-Years
21%
CAGR 10-Years
N/A
L
Leef Brands Inc
CNSX:LEEF
Long-Term Debt
$21m
CAGR 3-Years
38%
CAGR 5-Years
98%
CAGR 10-Years
N/A
No Stocks Found

Genix Pharmaceuticals Corp
Glance View

Market Cap
1.2m CAD
Industry
Consumer products

Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company is headquartered in Vancouver, British Columbia. The firm focused on developing and licensing novels and products for sales through retail outlets and well as direct to consumers and e-commerce platforms. The firm holds licensing agreement for a range of products, including 30 Ophthalmic drugs, Sucanon, Renochlor, Flu-X, and Levothyroxine sodium (generic Synthroid). Flu-X anti-viral spray is an herbal, oral, anti-viral, anti-flu and anti-cold virus spray. Renochlor is an aid in the restoration of kidney health and kidney function. Sucanon is a natural substitute for prescription pharmaceuticals for non-insulin dependent diabetes patients.

GENX Intrinsic Value
LOCKED
Unlock

See Also

What is Genix Pharmaceuticals Corp's Long-Term Debt?
Long-Term Debt
0 CAD

Based on the financial report for Oct 31, 2025, Genix Pharmaceuticals Corp's Long-Term Debt amounts to 0 CAD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett